Jiangsu Hengrui Medicine Co. Ltd Financials

Market Capitalization CN¥418.67 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	51.35
Forward PE	39.31
Price to Sales TTM	CN¥12.76
Price to Book MRQ	CN¥6.68
Enterprise to Revenue	11.54
Enterprise to EBITDA	41.72

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	24.10%
Operating Margin	21.49%
Return on Assets TTM	8.37%
Return on Equity TTM	14.34%

Income Statement

Revenue TTM	CN¥30,983,383,040
Revenue per Share TTM	CN¥4.81
Quarterly Revenue Growth	12.70%
Gross Profit TTM	CN¥26,740,408,320
EBITDA	CN¥8,246,370,699
Net Income to Common TTM	CN¥7,468,120,576
Diluted EPS TTM	CN¥1.16
Quarterly Earnings Growth YoY	9.50%

Balance Sheet

Total Cash MRQ	CN¥40,475,525,120
Total Cash per Share MRQ	CN¥6.07
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.14
Current Ratio MRQ	6.55
Book Value per Share MRQ	CN¥8.92

Cash Flow

Operating Cash Flow TTM	CN¥11,947,737,088
Levered Free Cash Flow TTM	CN¥8,450,120,704

600276 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	6,637,199,874
Float Shares	3,710,552,094
Avg 10 Volume	24,608,947
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	46.20%
% Held by Institutions	18.99%

Stock Price Summary

Beta	0.43
Fifty Two Week Low	CN¥42.40
Fifty Two Week High	CN¥74.04
Fifty Two Week Change	24.44%
Day 50 MA	CN¥61.98
Day 200 MA	CN¥59.42

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.80
Forward Annual Dividend Yield	1.34%
Trailing Annual Dividend Rate	CN¥0.20
Trailing Annual Dividend Yield	0.34%
Payout Ratio	17.24%
Dividend Date
Ex Dividend Date	2025-05-23
Last Split Factor
Last Split Date	2021-06-10